MedTrace Logo

PREG - Offspring: Investigation of Children From Mothers With and Without Gestational Diabetes

NCT04722900 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2021-09-02

No results posted yet for this study

Summary

Gestational diabetes is the most common complication during pregrancy. With a screening between week 24 and 28 of gestation women with gestational diabetes can be identified and treated. Treatment comprises modification of diet and in some cases taking medication. This treatment lowers undesirable events like macrosomia or premature birth. However, unitl gestational diabetes is diagnosed the fetus is exposed to increased intrauterine glucose levels. The long-term effects of a well-managed gestational diabetes on the development of the offspring is still not well understood. Therefore, the PREG - Offspring study investigates several aspects of development in children from healthy and gestational diabetes mothers until adulthood.

Conditions

  • Offspring Exposed to GDM and Control

Interventions

OTHER

intrauterine exposure to elevated glucose levels

intrauterine exposure to elevated glucose levels

Sponsors & Collaborators

  • University Hospital Tuebingen

    lead OTHER

Principal Investigators

  • Andreas Fritsche · University Hospital Tübingen

Eligibility

Min Age
6 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-15
Primary Completion
2036-01-15
Completion
2036-09-15

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04722900 on ClinicalTrials.gov